Alliancebernstein L.P. Praxis Precision Medicines, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $32,147 - $623,295	17,100 Added 26.89%	80,700 $192,000
Q3 2022 Nov 15, 2022	BUY	$2.5 - $37.95 $25,750 - $390,885	10,300 Added 19.32%	63,600 $144,000
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $3.49 Million - $22.6 Million	-1,996,540 Reduced 97.4%	53,300 $131,000
Q1 2022 May 13, 2022	BUY	$10.21 - $20.29 $1.8 Million - $3.58 Million	176,330 Added 9.41%	2,049,840 $20.9 Million
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $3.83 Million - $5.25 Million	228,502 Added 13.89%	1,873,510 $36.9 Million
Q3 2021 Nov 10, 2021	BUY	$13.15 - $22.56 $2.97 Million - $5.09 Million	225,640 Added 15.9%	1,645,008 $30.4 Million
Q2 2021 Jul 30, 2021	BUY	$18.28 - $33.05 $9.65 Million - $17.4 Million	527,815 Added 59.2%	1,419,368 $25.9 Million
Q1 2021 May 06, 2021	BUY	$29.34 - $60.2 $5.73 Million - $11.8 Million	195,301 Added 28.05%	891,553 $29.2 Million
Q4 2020 Feb 08, 2021	BUY	$27.25 - $55.82 $19 Million - $38.9 Million	696,252 New	696,252 $38.3 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.